Evidence map›Paper›PMID 37635364›Full record

ArticlePathogens and global health2024

Genetic diversity and evolutionary dynamics of the Omicron variant of SARS-CoV-2 in Morocco.

Safae El Mazouri, Abdelmounim Essabbar, Tarik Aanniz, Rachid Eljaoudi, Lahcen Belyamani, Azeddine Ibrahimi, Mouna Ouadghiri

Abstract read
In one paragraph

Article in Pathogens and global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Safae El MazouriLaboratory of Biotechnology, Medical and Pharmacy School, Mohammed V University, Rabat, Morocco.
Abdelmounim EssabbarLaboratory of Biotechnology, Medical and Pharmacy School, Mohammed V University, Rabat, Morocco.
Tarik AannizLaboratory of Biotechnology, Medical and Pharmacy School, Mohammed V University, Rabat, Morocco.
Rachid EljaoudiLaboratory of Biotechnology, Medical and Pharmacy School, Mohammed V University, Rabat, Morocco.
Lahcen BelyamaniLaboratory of Biotechnology, Medical and Pharmacy School, Mohammed V University, Rabat, Morocco.
Azeddine IbrahimiLaboratory of Biotechnology, Medical and Pharmacy School, Mohammed V University, Rabat, Morocco.
Mouna OuadghiriLaboratory of Biotechnology, Medical and Pharmacy School, Mohammed V University, Rabat, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among the numerous variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that have been reported worldwide, the emergence of the Omicron variant has drastically changed the landscape of the coronavirus disease (COVID-19) pandemic. Here, we analyzed the genetic diversity of Moroccan SARS-CoV-2 genomes with a focus on Omicron variant after one year of its detection in Morocco in order to understand its genomic dynamics, features and its potential introduction sources. From 937 Omicron genomes, we identified a total of 999 non-unique mutations distributed across 92 Omicron lineages, of which 13 were specific to the country. Our findings suggest multiple introductory sources of the Omicron variant to Morocco. In addition, we found that four Omicron clades are more infectious in comparison to other Omicron clades. Remarkably, a clade of Omicron is particularly more transmissible and has become the dominant variant worldwide. Moreover, our assessment of Receptor-Binding Domain (RBD) mutations showed that the Spike K444T and N460K mutations enabled a clade higher ability of immune vaccine escape. In conclusion, our analysis highlights the unique genetic diversity of the Omicron variant in Moroccan SARS-CoV-2 genomes, with multiple introductory sources and the emergence of highly transmissible clades. The distinctiveness of the Moroccan strains compared to global ones underscores the importance of ongoing surveillance and understanding of local genomic dynamics for effective response strategies in the evolving COVID-19 pandemic.

Indexed as

COVID-19Genetic VariationGenome, ViralMutationSARS-CoV-2Spike Glycoprotein, CoronavirusEvolution, MolecularHumansMoroccoPhylogenySpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2next-generation sequencingomicronphylogenetic analysisSARS-CoV-2 genomic surveillancespike proteinvariants of concern

Identifiers

PMID37635364
PMCPMC11221468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.